BMY - Bristol-Myers gets EU approval for Opdivo for bladder cancer
2024-05-29 10:04:43 ET
More on Bristol-Myers Squibb Company
- Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity
- Bristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 Transcript
- Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)
- Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
- Bristol-Myers Squibb snaps six days of losses, trades in the green